Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 InhibitorsMichaela Waibel, Ricky W. Johnstone|Cell Reports|2013Cited by 134